General Information
Version
UK Page 1 of 12
Revision date
2023-10-13
Product name
HTRF d2-NHS - 10 mg 65D2SABC
1.2.1 Relevant identified uses
Use of the substance or mixture for Laboratory Research use only ;
1.2.2. Uses advised against
Do not use for diagnostics, therapeutics or other clinical uses. ;
supplier name
CISBIO BIOASSAYS, company of Revvity Group
Emergency telephone
France - Numéro ORFILA (INRS) : + 33 (0)1 45 42 59 59
Icons in SDS
Company Information
company name
CISBIO BIOASSAYS, company of Revvity Group
e-mail address of the competent person responsible for the Safety Data Sheet
codolet.sds@revvity.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318
Hazard statements
Code
Statements
H318
Causes serious eye damage.
Section 2
SECTION 2: Hazards identification
Precautionary statements
P280 Serious eye damage/eye irritation - Eye Dam. 1 - H318 Eye Dam. 1 H318 P305 + P351 + P338 P310
2.2 Label elements
Labelling
Product definition
Designation / Commercial name : HTRF d2-NHS - 10 mg 65D2SABC Substances contained in this product: Substance name CAS n° Index n° EC n° Version UK Page 2 of 12 Revision Date: 13/10/2023 D2 NOCAS5
Hazard pictograms
GHS05-acid
Signal word
Danger Hazard and precautionary statements: Code Hazard statments H318 Causes serious eye damage. P280 Wear protective gloves/protective clothing/eye protection/face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 Immediately call a POISON CENTER/doctor/…
2.3 Other hazards
The mixture does not contain substances classified as ‘Substances of Very High Concern' (SVHC) >= 0.1% published by the European CHemicals Agency (ECHA) under article 57 of REACH. The mixture satisfies neither the PBT nor the vPvB criteria for mixtures in accordance with annexe XIII of the REACH regulations EC
Potential health effects
Version UK Page 3 of 12 Revision Date: 13/10/2023